For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced mortality, myocardial ...

New classes of drugs like the SGLT-2 Inhibitors and GLP-1 Receptor Agonists  have tremendous potential for managing the blood ...

Facing with a dialogue with RFK Jr., a top FDA official mounts a public defense of vaccines — and pleads for open minds.

This clinical trial is a randomized, double-blind study designed to enroll 120 patients across four treatment groups. The primary endpoint will evaluate the difference in weight loss of nimacimab ...

Terns Pharmaceuticals, Inc. ( (TERN) ) has released its Q3 earnings. Here is a breakdown of the information Terns Pharmaceuticals, Inc.

Skye Bioscience, Inc. (Nasdaq: SKYE) ("Skye"), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associ ...

Dr Menon believes that lifestyle modifications are “essential in managing diabetes and preventing complications.” His ...

The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September, and according to ...

A new guideline released on World Diabetes Day will give GPs and other health professionals positive recommendations for optimal diabetes management ...

From November 11 to 14, 2024, Singclean showcased its cutting-edge medical and skincare innovations at MEDICA, the world's ...

We believe our truly peripherally-restricted CB1 inhibitor has the differentiated attributes necessary ... and is also assessing synergistic outcomes when nimacimab is combined with semaglutide, a GLP ...